SURPASS Impella 5.5 Study

CompletedOBSERVATIONAL
Enrollment

1,017

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

May 14, 2025

Study Completion Date

May 14, 2025

Conditions
Cardiogenic ShockAcute Decompensated Heart Failure
Interventions
DEVICE

Impella 5.5

Impella 5.5 mechanical circulatory support

Trial Locations (15)

15219

University of Pittsburgh Medical Center, Pittsburgh

29425

Medical University of South Carolina, Charleston

30322

Emory University Hospital, Atlanta

33606

Tampa General Hospital, Tampa

44195

Cleveland Clinic, Cleveland

60208

Northwestern University, Evanston

73112

Integris Health Baptist Medical Center, Oklahoma City

77030

Memorial Hermann Texas Medical Center, Houston

78229

Methodist San Antonio Hospital, San Antonio

90048

Cedars Sinai Medical Center, Los Angeles

302803

Advent Health Orlando, Orlando

02111

Tufts Medical Center, Boston

02114

MGH, Boston

07601

Hackensack University Medical Center, Hackensack

08901

The Robert Wood Johnson University Hospital, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abiomed Inc.

INDUSTRY